Ohio; Tax Secured, General Obligation Dec 03

  • ID: 1815196
  • December 2003
  • Region: Ohio
  • Standard & Poors

The 'AA+' rating on the state of Ohio's unlimited-tax GO bonds reflects: The state's vast, broad, and diverse economic base, which includes several regional centers and corporate headquarters; An economic base anchored by manufacturing, with expanding health care and technology sectors; Unemployment rates and income levels that approximate the national averages; and The state operating under a structurally balanced fiscal 2004-2005 biennial budget, along with the implementation of a broad-based tax increase, albeit temporary, in the form of a one-cent increase in the sales tax rate, as well as conservative assumptions for economic growth underlying budget projections. While the increase in the sales tax is temporary, it provides the state with the foundation to achieve structural balance for the current...

Companies mentioned in this report are:
- Ohio

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown


Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.